Key Metrics
CiteScore 

4.1
H-Index 

90
Impact Factor 

< 5
SJR 

Q1Pharmacology (medical)

SNIP 

1.02
Recommended pre-submission checks
Powered by 

Topics Covered on Journal of Child and Adolescent Psychopharmacology
Journal of Child and Adolescent Psychopharmacology Journal Specifications
| Overview | |
| Publisher | MARY ANN LIEBERT, INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1990 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Journal of Child and Adolescent Psychopharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Journal of Child and Adolescent Psychopharmacology
Efficacy and Safety of Cannabinoid-Based Products in Children and Adolescents with Autism Spectrum Disorder, Fragile X Syndrome and Rett Syndrome: A Systematic Review.
- 1 Sep 2026
- Journal of child and adolescent psychopharmacology
Letter: Restricted Access to Electroconvulsive Therapy in Pediatric and Adolescent Patients-Clinical and Familial Consequences: Case Report.
- 8 Aug 2026
- Journal of child and adolescent psychopharmacology
Amantadine-Responsive, Benzodiazepine-Resistant Catatonia in an Adolescent With Autism Spectrum Disorder.
- 7 Aug 2026
- Journal of child and adolescent psychopharmacology
Letter: Elevated Prolactin as a Potential Clinical Clue for Sensitivity to D2 Antagonism in an Adolescent Female Presenting with Recurrent Oculogyric Crises--A Case Study.
- 7 Aug 2026
- Journal of child and adolescent psychopharmacology
A Phase-2 Open-Label Trial of Cannabidiol to Treat Core and Associated Symptoms of Autism in Children and Adolescents Without Intellectual Disability.
- 1 Aug 2026
- Journal of child and adolescent psychopharmacology
Effectiveness and Safety of Selective Serotonin Reuptake Inhibitors in Individuals with Williams Syndrome.
- 1 Aug 2026
- Journal of child and adolescent psychopharmacology
Efficacy and Safety of Cannabinoid-Based Products in Children and Adolescents with Autism Spectrum Disorder, Fragile X Syndrome and Rett Syndrome: A Systematic Review.
- 1 Sep 2026
- Journal of child and adolescent psychopharmacology
Letter: Restricted Access to Electroconvulsive Therapy in Pediatric and Adolescent Patients-Clinical and Familial Consequences: Case Report.
- 8 Aug 2026
- Journal of child and adolescent psychopharmacology
Amantadine-Responsive, Benzodiazepine-Resistant Catatonia in an Adolescent With Autism Spectrum Disorder.
- 7 Aug 2026
- Journal of child and adolescent psychopharmacology
Letter: Elevated Prolactin as a Potential Clinical Clue for Sensitivity to D2 Antagonism in an Adolescent Female Presenting with Recurrent Oculogyric Crises--A Case Study.
- 7 Aug 2026
- Journal of child and adolescent psychopharmacology
A Phase-2 Open-Label Trial of Cannabidiol to Treat Core and Associated Symptoms of Autism in Children and Adolescents Without Intellectual Disability.
- 1 Aug 2026
- Journal of child and adolescent psychopharmacology
Effectiveness and Safety of Selective Serotonin Reuptake Inhibitors in Individuals with Williams Syndrome.
- 1 Aug 2026
- Journal of child and adolescent psychopharmacology